MR

Active Director Director DIN 08054743
DIN 08054743 First appointment Oct 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Oct 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Munna Ram

Data last updated:

Munna Ram is a Director at Harrill Pharmaceutical Private Limited (since 2023) and Director at Phyllan Pharmaceutical Private Limited (since 2020). The companies operate in Pharma.

DIN 08054743
Primary Designation Director
Industry Pharma
First Appointment 10 Oct 2020
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jan 20232023Active
Director10 Oct 20202018Active

Directorship timeline

Open interactive timeline →
Phyllan Pharmaceutical Private Limited
Harrill Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Munna Ram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Munna Ram

Munna Ram currently holds 2 directorships: Harrill Pharmaceutical Private Limited (Director, since 05 Jan 2023); Phyllan Pharmaceutical Private Limited (Director, since 10 Oct 2020).

Munna Ram was first appointed on 10 Oct 2020 as Director at Phyllan Pharmaceutical Private Limited. The most recent appointment on record is 05 Jan 2023 at Harrill Pharmaceutical Private Limited.

The current boards of Munna Ram's companies include Sudha Kumari (Harrill Pharmaceutical Private Limited), Tanya Kaushik (Phyllan Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available